TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis

NCT04589260 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
72
Enrollment
INDUSTRY
Sponsor class

Stopped The Sponsor has decided to stop the study due to business reasons. Study was terminated before initiation of part C and D (Decision to not proceed with Parts C and D was not for safety reasons and do not impact the overall risk benefit of the IMP.)

Conditions

Interventions

Sponsor

Theravance Biopharma